Serum Antibodies to Glycans in Peripheral Neuropathies
- PMID: 26867654
- DOI: 10.1007/s12035-016-9775-8
Serum Antibodies to Glycans in Peripheral Neuropathies
Abstract
In peripheral neuropathies, such as sensorimotor neuropathies, motor neuron diseases, or the Guillain-Barré syndrome, serum antibodies recognizing saccharide units, portion of oligosaccharides, or oligosaccharide chains, have been found. These antibodies are called anti-glycosphingolipid (GSL) or anti-ganglioside antibodies. However, the information on the aglycone carrying the hydrophilic oligosaccharide remains elusive. The absolute and unique association of GSL to the onset, development and symptomatology of the peripheral neuropathies could be misleading. Here, we report some thoughts on the matter.
Keywords: Glycoconjugates; Mimicry; Oligosaccharides; Peripheral neuropathies; Serum antibodies.
Similar articles
-
Autoimmune peripheral neuropathies.Clin Chim Acta. 2015 Sep 20;449:37-42. doi: 10.1016/j.cca.2015.02.039. Epub 2015 Mar 4. Clin Chim Acta. 2015. PMID: 25748038 Review.
-
[Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].Ann Biol Clin (Paris). 1999 Sep-Oct;57(5):579-88. Ann Biol Clin (Paris). 1999. PMID: 10518060 French.
-
Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Mol Neurobiol. 2016 Sep;53(7):4981-91. doi: 10.1007/s12035-015-9430-9. Epub 2015 Sep 15. Mol Neurobiol. 2016. PMID: 26374552 Review.
-
Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.J Neurol. 2015 Aug;262(8):1954-60. doi: 10.1007/s00415-015-7806-4. Epub 2015 Jun 9. J Neurol. 2015. PMID: 26050638
-
Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.J Neurosci Res. 2005 Apr 1;80(1):1-17. doi: 10.1002/jnr.20395. J Neurosci Res. 2005. PMID: 15668908 Review.
Cited by
-
The Neuroprotective Role of the GM1 Oligosaccharide, II3Neu5Ac-Gg4, in Neuroblastoma Cells.Mol Neurobiol. 2019 Oct;56(10):6673-6702. doi: 10.1007/s12035-019-1556-8. Epub 2019 Mar 26. Mol Neurobiol. 2019. PMID: 30911934
-
GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.Int J Mol Sci. 2020 Jan 29;21(3):868. doi: 10.3390/ijms21030868. Int J Mol Sci. 2020. PMID: 32013258 Free PMC article. Review.
-
GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.Int J Mol Sci. 2020 Apr 19;21(8):2858. doi: 10.3390/ijms21082858. Int J Mol Sci. 2020. PMID: 32325905 Free PMC article.
-
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse model.Sci Rep. 2019 Dec 18;9(1):19330. doi: 10.1038/s41598-019-55885-2. Sci Rep. 2019. PMID: 31852959 Free PMC article.
-
Glycosphingolipids.Adv Exp Med Biol. 2021;1325:61-102. doi: 10.1007/978-3-030-70115-4_3. Adv Exp Med Biol. 2021. PMID: 34495530
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical